Connection
Robert Freedman to Nicotinic Antagonists
This is a "connection" page, showing publications Robert Freedman has written about Nicotinic Antagonists.
|
|
Connection Strength |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_left.gif) |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_right.gif) |
|
0.248 |
|
|
|
-
Adams CE, Freedman R. Nicotinic antagonist alpha-bungarotoxin binding to rat hippocampal neurons containing nitric oxide synthase. Brain Res. 1997 Nov 21; 776(1-2):111-6.
Score: 0.150
-
Adams CE, Stevens KE, Kem WR, Freedman R. Inhibition of nitric oxide synthase prevents alpha 7 nicotinic receptor-mediated restoration of inhibitory auditory gating in rat hippocampus. Brain Res. 2000 Sep 22; 877(2):235-44.
Score: 0.046
-
Leonard S, Adams C, Breese CR, Adler LE, Bickford P, Byerley W, Coon H, Griffith JM, Miller C, Myles-Worsley M, Nagamoto HT, Rollins Y, Stevens KE, Waldo M, Freedman R. Nicotinic receptor function in schizophrenia. Schizophr Bull. 1996; 22(3):431-45.
Score: 0.033
-
Simosky JK, Freedman R, Stevens KE. Olanzapine improves deficient sensory inhibition in DBA/2 mice. Brain Res. 2008 Oct 03; 1233:129-36.
Score: 0.020